chemistry

Levacetylleucine

Levacetylleucine is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Levacetylleucine rather than just read about it. In short: Levacetylleucine (N-acetyl-L-leucine), sold under the brand name Aqneursa, is a medication used for the treatment of neurological manifestations of Niemann-Pick disease type C. Levacetylleucine is a modified version of the amino acid leucine.

Key takeaways

Levacetylleucine belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Levacetylleucine to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Levacetylleucine from memory before moving on to harder problems.

Reference excerpt

Levacetylleucine (N-acetyl-L-leucine), sold under the brand name Aqneursa, is a medication used for the treatment of neurological manifestations of Niemann-Pick disease type C. Levacetylleucine is a modified version of the amino acid leucine. It is the L-form of acetylleucine. It is taken by mouth. The most common side effects include abdominal pain, difficulty swallowing, upper respiratory tract infections, and vomiting. Levacetylleucine was approved for medical use in the United States in September 2024, and in the European Union in January 2026. Levacetylleucine is the second medication approved by the US Food and Drug Administration (FDA) for the treatment of Niemann-Pick disease type C. The FDA considers it to be a first-in-class medication.

Medical uses Levacetylleucine is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C in people weighing at least 15 kilograms (33 lb).

Adverse effects The most common side effects include abdominal pain, difficulty swallowing, upper respiratory tract infections, and vomiting. Levacetylleucine may cause embryo-fetal harm if used during pregnancy.

History The safety and efficacy of levacetylleucine for the treatment of Niemann-Pick disease type C were evaluated in a randomized, double-blind, placebo-controlled, two-period, 24-week crossover study. The duration was twelve weeks for each treatment period. The study enrolled 60 participants. To be eligible for the study participants had to be four years of age or older with a confirmed diagnosis of Niemann-Pick disease type C and at least mild disease-related neurological symptoms. Participants could receive miglustat, an enzyme inhibitor, as background treatment in the study. The trial was conducted at eleven sites in seven countries in Europe and Australia. The US Food and Drug Administration (FDA) granted the application for levacetylleucine priority review, fast track, orphan drug, and rare pediatric disease designations. The FDA granted approval of Aqneursa to IntraBio Inc.

Society and culture

Legal status Levacetylleucine was approved for medical use in the United States in September 2024. In July 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Aqneursa, intended for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) disease in adults and children from six years of age weighing at least 20 kilograms (44 lb). The applicant for this medicinal product is IntraBio Ireland Ltd. The CHMP concluded that the active substance, levacetylleucine, could not be considered a new active substance; this conclusion was confirmed in November 2025 after re-examination of the initial opinion. Levacetylleucine was authorized for medical use in the European Union in January 2026.

Names Levacetylleucine is the international nonproprietary name. Levacetylleucine is sold under the brand name Aqneursa.

Research Levacetylleucine is being studied for the treatment of GM2 gangliosidoses (Tay-Sachs and Sandhoff diseases), ataxia-telangiectasia, Lewy body dementia, amyotrophic lateral sclerosis, restless legs syndrome, multiple sclerosis, and migraine.

References

Illustrations

Worked examples

Example 1 — a first encounter with Levacetylleucine

Start with the simplest possible case. Write down what Levacetylleucine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Levacetylleucine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Levacetylleucine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Levacetylleucine

In research: Levacetylleucine appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Levacetylleucine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Levacetylleucine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Amides, Amino acids, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Levacetylleucine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Levacetylleucine in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Levacetylleucine means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Levacetylleucine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Levacetylleucine in simple terms?

Why does Levacetylleucine matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Levacetylleucine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Levacetylleucine.